ProCE Banner Activity

Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy in English (Podcast Pearls)

PDF
Experts from Italy provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Released: March 01, 2021

Expiration: February 28, 2022

No longer available for credit.

Share

Faculty

Giuseppe Procopio

Giuseppe Procopio, MD

Head of the Medical Oncology Genitourinary, Istituto Nazionale Tumori
Medical Oncology
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy

Cora N. Sternberg

Cora N. Sternberg, MD

Supporters

Supported by an educational grant from

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Giuseppe Procopio, MD

Head of the Medical Oncology Genitourinary, Istituto Nazionale Tumori
Medical Oncology
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy

Cora N. Sternberg, MD